• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性导管乳腺癌全转录谱及特定通路的测定

Determination of whole transcription profiles and specific pathways in invasive ductal breast carcinoma.

作者信息

Arnutti Pasra, Kotepui Manas, Asanprakit Wichitra, Punyarit Phaibul, Chavalitshewinkoon-Petmitr Porntip, Harnroongroj Talabporn, Petmitr Songsak

机构信息

Department of Tropical Nutrition & Food Science, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.

出版信息

Int J Clin Exp Pathol. 2013 May 15;6(6):1112-20. Print 2013.

PMID:23696929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3657364/
Abstract

Breast cancer is the most common cancer affecting women worldwide including Thailand. Whole transcription profiles of invasive ductal breast carcinoma (IDC) obtained by oligonucleotide microarray should lead to a better understanding of the molecular basis of IDCs, allow for examination of specific markers for diagnosis, and provide novel targets for therapy. This study aimed to detect the whole transcript expression of approximately 35,000 target genes in Thai breast cancer patients, using Affymetrix GeneChip(®) Exon 1.0 Sense Target Arrays. Analysis revealed that the differential expression profiles of 928 genes (423 up-regulated and 505 down-regulated genes) were 2-fold or greater (unpaired t-test, p < 0.05) in invasive ductal breast cancer, compared with normal tissues. The Gene Ontology (GO) databases support important associations in 17 gene sets with p-value < 1E-10 and ≥ 4-fold changes, involving the tumorigenic pathways of cell cycles, extracellular regions, as well as cellular component organization. Likewise, the TGFBR and IL-6 pathways contain gene expression with statistically significant changes in IDC.

摘要

乳腺癌是包括泰国在内的全球女性中最常见的癌症。通过寡核苷酸微阵列获得的浸润性导管癌(IDC)的全转录谱,应能更好地理解IDC的分子基础,有助于检查诊断的特异性标志物,并为治疗提供新靶点。本研究旨在使用Affymetrix GeneChip(®) Exon 1.0 Sense Target Arrays检测泰国乳腺癌患者中约35000个靶基因的全转录表达。分析显示,与正常组织相比,浸润性导管癌中928个基因(423个上调基因和505个下调基因)的差异表达谱为2倍或更高(未配对t检验,p < 0.05)。基因本体论(GO)数据库支持17个基因集的重要关联,p值< 1E-10且变化≥ 4倍,涉及细胞周期、细胞外区域以及细胞成分组织的致瘤途径。同样,TGFBR和IL-6途径在IDC中包含具有统计学显著变化的基因表达。

相似文献

1
Determination of whole transcription profiles and specific pathways in invasive ductal breast carcinoma.浸润性导管乳腺癌全转录谱及特定通路的测定
Int J Clin Exp Pathol. 2013 May 15;6(6):1112-20. Print 2013.
2
Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.基因表达谱分析显示,MCM3 作为标志物在预测浸润性导管乳腺癌患者预后方面优于 Ki67。
Clin Exp Med. 2020 May;20(2):249-259. doi: 10.1007/s10238-019-00604-4. Epub 2020 Jan 24.
3
Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.浸润性导管乳腺癌的转录表达、拷贝数和 LOH 分析的整合。
BMC Cancer. 2010 Aug 27;10:460. doi: 10.1186/1471-2407-10-460.
4
Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue.在组织学正常的乳腺组织中,增殖基因在恶性风险基因特征中占主导地位。
Breast Cancer Res Treat. 2010 Jan;119(2):335-46. doi: 10.1007/s10549-009-0344-y. Epub 2009 Mar 6.
5
Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.通过对匹配的原位导管癌和浸润性乳腺肿瘤进行表达谱分析,结合激光捕获显微切割和寡核苷酸微阵列分析鉴定出的进展特异性基因。
Cancer Res. 2006 May 15;66(10):5278-86. doi: 10.1158/0008-5472.CAN-05-4610.
6
Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women.特定年龄段的乳腺癌基因表达特征,以及年轻女性中跨物种保守的潜在癌症进展标志物。
PLoS One. 2013 May 21;8(5):e63204. doi: 10.1371/journal.pone.0063204. Print 2013.
7
Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis.通过激光显微切割和微阵列分析鉴别小叶型和导管型浸润性乳腺癌的新型标志物
BMC Cancer. 2007 Mar 27;7:55. doi: 10.1186/1471-2407-7-55.
8
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.使用 array-CGH 预测遗传性乳腺癌中的 BRCA2 相关性。
Breast Cancer Res Treat. 2012 Apr;132(2):379-89. doi: 10.1007/s10549-010-1016-7. Epub 2010 Jul 8.
9
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.分析导管原位癌肿瘤微环境中的基质特征。
Breast Cancer Res Treat. 2010 Sep;123(2):397-404. doi: 10.1007/s10549-009-0654-0. Epub 2009 Dec 1.
10
Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.导管原位癌和浸润性乳腺肿瘤的基因表达谱分析
Anticancer Res. 2003 May-Jun;23(3A):2043-51.

引用本文的文献

1
Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis.DDR2 和 IFITM1 的共表达促进乳腺癌细胞的增殖、迁移和侵袭,抑制细胞凋亡。
J Cancer Res Clin Oncol. 2022 Dec;148(12):3385-3398. doi: 10.1007/s00432-022-04110-1. Epub 2022 Jun 28.
2
Coexpression of EphA10 and Gli3 promotes breast cancer cell proliferation, invasion and migration.EphA10 和 Gli3 的共表达促进乳腺癌细胞的增殖、侵袭和迁移。
J Investig Med. 2021 Aug;69(6):1215-1221. doi: 10.1136/jim-2021-001836. Epub 2021 May 14.
3
Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient.CDCA3、CDCA5和CDCA8的不同表达导致乳腺癌患者无复发生存期缩短。
Oncotarget. 2018 Jan 9;9(6):6977-6992. doi: 10.18632/oncotarget.24059. eCollection 2018 Jan 23.
4
LAMP1 expression is associated with poor prognosis in breast cancer.LAMP1表达与乳腺癌的不良预后相关。
Oncol Lett. 2017 Oct;14(4):4729-4735. doi: 10.3892/ol.2017.6757. Epub 2017 Aug 16.

本文引用的文献

1
Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.在浸润性乳腺癌中,cyclin B2 的表达升高与不良的临床结局相关。
BMC Cancer. 2013 Jan 2;13:1. doi: 10.1186/1471-2407-13-1.
2
Absence of TGF-βRII predicts bone and lung metastasis and is associated with poor prognosis in stage III breast tumors.TGF-βRII 的缺失预示着骨转移和肺转移,并与 III 期乳腺癌肿瘤的不良预后相关。
Cancer Biomark. 2012;11(5):209-17. doi: 10.3233/CBM-2012-00281.
3
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.乳腺癌炎症分子谱与远处转移发展的关系。
PLoS One. 2012;7(11):e49047. doi: 10.1371/journal.pone.0049047. Epub 2012 Nov 8.
4
FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels.FABP4 动力学在肥胖中的作用:脂肪组织和肝脏表达与循环血浆水平之间的差异。
PLoS One. 2012;7(11):e48605. doi: 10.1371/journal.pone.0048605. Epub 2012 Nov 5.
5
COL10A1 expression is elevated in diverse solid tumor types and is associated with tumor vasculature.COL10A1 在多种实体肿瘤类型中表达上调,并与肿瘤血管有关。
Future Oncol. 2012 Aug;8(8):1031-40. doi: 10.2217/fon.12.79.
6
Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest.细胞周期调控因子 CDCA3 的过表达通过促进细胞增殖来促进口腔癌的进展,同时防止 G1 期阻滞。
BMC Cancer. 2012 Jul 28;12:321. doi: 10.1186/1471-2407-12-321.
7
Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma.PTTG1 癌基因的表达与侵袭性透明细胞肾细胞癌相关。
Cancer Res. 2012 Sep 1;72(17):4361-71. doi: 10.1158/0008-5472.CAN-11-2330. Epub 2012 Jul 17.
8
Global estimates of cancer prevalence for 27 sites in the adult population in 2008.2008 年全球 27 个成人部位癌症发病估计数。
Int J Cancer. 2013 Mar 1;132(5):1133-45. doi: 10.1002/ijc.27711. Epub 2012 Jul 26.
9
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review.Ki-67:在乳腺癌临床管理中应用的证据水平和方法学考虑因素:分析和批判性评价。
Breast Cancer Res Treat. 2012 Apr;132(3):895-915. doi: 10.1007/s10549-011-1837-z. Epub 2011 Nov 3.
10
Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.周期素依赖性激酶 5 在胰腺癌中扩增和过表达,并被突变型 K-Ras 激活。
Clin Cancer Res. 2011 Oct 1;17(19):6140-50. doi: 10.1158/1078-0432.CCR-10-2288. Epub 2011 Aug 8.